149 related articles for article (PubMed ID: 35621052)
21. [The epidemiology of the gastroduodenal damage induced by aspirin and other nonsteroidal anti-inflammatory drugs].
Dobrilla G; Benvenuti S; de Guelmi A
Recenti Prog Med; 1997 May; 88(5):202-11. PubMed ID: 9244954
[TBL] [Abstract][Full Text] [Related]
22. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons.
Smalley WE; Ray WA; Daugherty JR; Griffin MR
Am J Epidemiol; 1995 Mar; 141(6):539-45. PubMed ID: 7900721
[TBL] [Abstract][Full Text] [Related]
23. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
Goldstein JL; Cryer B; Amer F; Hunt B
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
[TBL] [Abstract][Full Text] [Related]
24. Risk of upper gastrointestinal ulcers in patients with osteoarthritis receiving single-tablet ibuprofen/famotidine versus ibuprofen alone: pooled efficacy and safety analyses of two randomized, double-blind, comparison trials.
Bello AE; Kent JD; Grahn AY; Rice P; Holt RJ
Postgrad Med; 2014 Jul; 126(4):82-91. PubMed ID: 25141246
[TBL] [Abstract][Full Text] [Related]
25. Nonsteroidal anti-inflammatory drug-induced gastric damage: epidemiology.
Shorrock CJ; Langman MJ
Dig Dis; 1995 Jan; 13 Suppl 1():3-8. PubMed ID: 7697900
[TBL] [Abstract][Full Text] [Related]
26. [Upper gastrointestinal bleeding in patients treated by low-dose aspirin].
Capet C; Czernichow P; Dupas JL; Goria O; Gouérou H; Hochain P; Amouretti M; Herman H; Colin R
Gastroenterol Clin Biol; 2001 Mar; 25(3):233-8. PubMed ID: 11395668
[TBL] [Abstract][Full Text] [Related]
27. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population.
García Rodríguez LA; Barreales Tolosa L
Gastroenterology; 2007 Feb; 132(2):498-506. PubMed ID: 17258728
[TBL] [Abstract][Full Text] [Related]
28. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s.
Hernández-Díaz S; Rodríguez LA
Arch Intern Med; 2000 Jul; 160(14):2093-9. PubMed ID: 10904451
[TBL] [Abstract][Full Text] [Related]
29. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
[TBL] [Abstract][Full Text] [Related]
30. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
31. Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction.
Nema H; Kato M
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S119-21. PubMed ID: 20586852
[TBL] [Abstract][Full Text] [Related]
32. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
Karateev AE; Nasonova VA
Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
[TBL] [Abstract][Full Text] [Related]
33. Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study.
Yilmaz S; Bayan K; Dursun M; Canoruç F; Kilinç N; Tüzün Y; Daniş R; Ertem M
Dig Dis Sci; 2007 Jan; 52(1):110-8. PubMed ID: 17151802
[TBL] [Abstract][Full Text] [Related]
34. Endoscopic evaluation of low-dose aspirin-induced gastric and duodenal ulcers during prophylaxis with lansoprazole.
Sakaki N; Ashida K; Mizokami Y; Chiba T; Matsui S; Kanto T; Uemura N; Hiramatsu N; Sugano K
Hepatogastroenterology; 2013 Jun; 60(124):762-7. PubMed ID: 23478070
[TBL] [Abstract][Full Text] [Related]
35. Impact of upper gastrointestinal lesions in patients on low-dose aspirin therapy: preliminary study.
Kawai T; Watanabe M; Yamashina A
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S23-30. PubMed ID: 20586861
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.
Yeomans N; Lanas A; Labenz J; van Zanten SV; van Rensburg C; Rácz I; Tchernev K; Karamanolis D; Roda E; Hawkey C; Nauclér E; Svedberg LE
Am J Gastroenterol; 2008 Oct; 103(10):2465-73. PubMed ID: 18637091
[TBL] [Abstract][Full Text] [Related]
37. The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations.
Kurata JH; Abbey DE
J Clin Gastroenterol; 1990 Jun; 12(3):260-6. PubMed ID: 2193980
[TBL] [Abstract][Full Text] [Related]
38. The risk of lower gastrointestinal bleeding in low-dose aspirin users.
Chen WC; Lin KH; Huang YT; Tsai TJ; Sun WC; Chuah SK; Wu DC; Hsu PI
Aliment Pharmacol Ther; 2017 Jun; 45(12):1542-1550. PubMed ID: 28449186
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.
Chen TS; Luo JC; Chang FY
J Gastroenterol Hepatol; 2010 May; 25(5):919-22. PubMed ID: 20074147
[TBL] [Abstract][Full Text] [Related]
40. Ulcer and bleeding complications and their relationship with dyspeptic symptoms in NSAIDs users: a transversal multicenter study.
Dib RA; Chinzon D; Fontes LH; de Sá Teixeira AC; Navarro-Rodriguez T
Scand J Gastroenterol; 2014 Jul; 49(7):785-9. PubMed ID: 24941264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]